A number of other analysts have also recently weighed in on the stock. BidaskClub upgraded shares of Henry Schein from a “hold” rating to a “buy” rating in a report on Wednesday, November 27th. Barrington Research reaffirmed a “buy” rating and issued a $75.00 price objective on shares of Henry Schein in a research note on Wednesday, November 6th. Zacks Investment Research lowered shares of Henry Schein from a “hold” rating to a “sell” rating and set a $71.00 price objective for the company. in a research note on Wednesday, November 6th. Cleveland Research reaffirmed a “hold” rating on shares of Henry Schein in a research note on Friday, November 1st. Finally, TheStreet raised shares of Henry Schein from a “c+” rating to a “b” rating in a research note on Monday, October 14th. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and five have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $72.08.
Shares of NASDAQ:HSIC opened at $69.15 on Tuesday. The stock has a market capitalization of $10.15 billion, a price-to-earnings ratio of 16.74, a PEG ratio of 2.71 and a beta of 0.84. Henry Schein has a 1-year low of $56.58 and a 1-year high of $72.81. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.92 and a current ratio of 1.63. The company has a 50 day moving average price of $66.42 and a 200 day moving average price of $65.84.
Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, November 5th. The company reported $0.90 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.86 by $0.04. The firm had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.52 billion. Henry Schein had a net margin of 4.66% and a return on equity of 15.93%. The firm’s revenue for the quarter was up 6.5% compared to the same quarter last year. During the same period last year, the firm posted $1.03 earnings per share. On average, sell-side analysts expect that Henry Schein will post 3.45 EPS for the current fiscal year.
Henry Schein announced that its Board of Directors has initiated a share repurchase plan on Thursday, October 31st that authorizes the company to buyback $400.00 million in shares. This buyback authorization authorizes the company to buy up to 4.3% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s leadership believes its stock is undervalued.
In other news, Vice Chairman James P. Breslawski sold 6,856 shares of the firm’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $66.96, for a total transaction of $459,077.76. Following the transaction, the insider now owns 242,190 shares in the company, valued at approximately $16,217,042.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Steven Paladino sold 21,370 shares of the firm’s stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $68.83, for a total transaction of $1,470,897.10. Following the transaction, the chief financial officer now owns 144,863 shares in the company, valued at approximately $9,970,920.29. The disclosure for this sale can be found here. Insiders have sold a total of 123,655 shares of company stock valued at $8,373,585 in the last three months. Company insiders own 1.06% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the company. Enterprise Financial Services Corp raised its holdings in Henry Schein by 101.3% in the 3rd quarter. Enterprise Financial Services Corp now owns 483 shares of the company’s stock worth $31,000 after acquiring an additional 243 shares during the period. Cullen Frost Bankers Inc. bought a new position in Henry Schein in the 2nd quarter worth $36,000. Ibex Wealth Advisors bought a new position in Henry Schein in the 2nd quarter worth $40,000. Meeder Asset Management Inc. bought a new position in Henry Schein in the 2nd quarter worth $59,000. Finally, Rational Advisors LLC raised its holdings in Henry Schein by 24.9% in the 2nd quarter. Rational Advisors LLC now owns 903 shares of the company’s stock worth $63,000 after acquiring an additional 180 shares during the period.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.